10x Genomics has acquired Proteintech Genomics for an undisclosed price, the companies said, in a deal driven by the buyer’s commitment to expanding its multiomics presence—in this case, by strategically expanding its proteomics capabilities.
The acquisition is intended to bring together 10x’s expertise in scalable single-cell and spatial biology platforms with Proteintech Genomics’ capabilities in protein detection. Founded in 2022, Proteintech Genomics specializes in life science technologies enabling researchers to apply single-cell and spatial multiomics tools toward discovery. The company develops fully optimized and highly multiplexed proteomic assays designed for ready integration into various single-cell and spatial analysis application workflows.
By helping researchers harmonize RNA and protein analysis, Proteintech Genomics has positioned itself as an alternative to the multiple vendors and their workflows traditionally needed to accomplish both analyses, as researchers increasingly combine transcriptomic- and proteomics-based data to gain complementary insights into cellular identity, state, and function.
“Proteintech Genomics strengthens…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
